Search Results
Dr. Whitman on Expanding the Benefit of Immunotherapy in Solid Tumors
Dr. Whitman on Improving Precision Medicine in Oncology
What is the latest for immunotherapy for solid tumors? Dr. Randy Sweis, UChicago, Medical Oncologist
Dr. Whitman on the Role of Pembrolizumab in Melanoma
Immunotherapy in common solid tumors: an overview
The Utility of Immunotherapy and Targeted Therapy in Solid Tumors
Sequencing and Timing: Unanswered Questions in Melanoma
Dr. Whitman on the Partnership Between Atlantic Health System, TGen and Origin
Highlights from SITC 2021 on immunotherapy in solid tumors
Targeting TIGIT to Extend Immunotherapy Benefits to More Cancer Patients
Cancer Immunotherapy: How It Works, Who Will Benefit with Dr. Steve Rosenberg (PART 1)
Who Benefits from Immunotherapy?
